欧美mv日韩mv国产-国产午夜一级片-一区二区在线 | 国-韩国无码一区二区三区免费视频-黄色a免费-欧美黄色大片免费观看-人人综合网-国产成人a在线观看视频免费-国内精品久久久久久久影视-国产老头和老太xxxx视频-高h放荡受浪受bl-国产又爽又黄又不遮挡视频-国产偷国产偷亚洲高清人乐享

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > lambdaYES - human B cell cDNA
最近瀏覽歷史
聯(lián)系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮(zhèn)海區(qū)莊市街道興莊路9號
  • 創(chuàng)e慧谷42號樓B幢401室
lambdaYES - human B cell cDNA
lambdaYES - human B cell cDNA
規(guī)格:
貨期:
編號:B229999
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規(guī)格:
凍干粉
斜面
甘油
平板


產(chǎn)品名稱 lambdaYES - human B cell cDNA
商品貨號 B229999
Designations lambdaYES - human B cell cDNA
Species Homo sapiens, human
Depositors SJ Elledge
Origin
B lymphocyte (EBV transformed)
Applications
To convert bacteriophage lambda clones to plasmid via the cre-lox recombination system, the use of host strain E. coli BNN 132 (ATCC 47059) is recommended.
Vector
Tissue: B lymphocyte (EBV transformed)
DNA: cDNA
Insert size range: 0.7 - 7 kb
Insert size range (kb): 0.7 - 7
Insert ends: XhoI adaptors
Insert site: XhoI
Number of independent recombinants: 1 x 10^8
Non-recombinants (%): 5
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Shipping Information Distributed: frozen bacteria-free lysate (volume: 0.4 mL)
Comments
To convert bacteriophage lambda clones to plasmid via the cre-lox recombination system, the use of host strain E. coli BNN 132 (ATCC 47059) is recommended.
References

Elledge SJ, et al. lambdaYES: a multifunctional cDNA expression vector for the isolation of genes by complementation of yeast and Escherichia coli mutations. Proc. Natl. Acad. Sci. USA 88: 1731-1735, 1991. PubMed: 1848010

梅經(jīng)理 17280875617 1438578920
胡經(jīng)理 13345964880 2438244627
周經(jīng)理 17757487661 1296385441
于經(jīng)理 18067160830 2088210172
沈經(jīng)理 19548299266 2662369050
李經(jīng)理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |